增强肾清除对危重烧伤患者哌拉西林与美罗培南暴露的影响
一项2023至2025年前瞻性观察研究在三级烧伤ICU纳入24例使用美罗培南或哌拉西林/他唑巴坦的成人患者,获得84份药物浓度与肾功能配对样本。增强肾清除(ARC,肌酐清除率>130 mL/min)与β-内酰胺类目标达成率显著降低相关,基于分离株MIC和折点MIC的目标达成率在无ARC时均更高。
要点
- 危重烧伤患者中ARC常见,显著降低β-内酰胺类抗生素目标达成率。
- 无ARC时基于分离株MIC的目标达成率为100.0%,有ARC时为71.4%。
- 基于折点MIC的目标达成率在无ARC时为74.6%,有ARC时仅38.1%。
核心结论
- ARC在危重烧伤患者中常见,并与β-内酰胺类目标达成率显著降低相关。
- 基于分离株MIC的目标通常可达成,但基于折点的阈值常低于治疗水平。
研究设计与样本
- 2023至2025年在三级烧伤ICU开展的前瞻性观察研究。
- 85例筛查患者中24例接受研究抗生素,获得84份配对样本。
- 每日评估药物浓度(HPLC法)和肾功能(基于尿肌酐的肌酐清除率)。
- ARC定义为肌酐清除率>130 mL/min。
- 目标达成定义为100% ƒT > MIC(分别针对EUCAST折点和分离株MIC)。
主要发现
- 基于分离株MIC的100% ƒT > MIC达成率:无ARC为100.0%,有ARC为71.4%(OR 0.019 [0.001-0.38],p < 0.001)。
- 基于折点MIC的100% ƒT > MIC达成率:无ARC为74.6%,有ARC为38.1%(OR 0.21 [0.07-0.60],p = 0.004)。
- 探索性分析提示肾功能保留和较低器官衰竭评分与亚治疗浓度相关。
关键数值与推荐
- ARC定义为肌酐清除率>130 mL/min。
- 目标达成定义为100% ƒT > MIC。
- 基于分离株MIC的达成率:无ARC 100.0% vs 有ARC 71.4%(OR 0.019 [0.001-0.38],p < 0.001)。
- 基于折点MIC的达成率:无ARC 74.6% vs 有ARC 38.1%(OR 0.21 [0.07-0.60],p = 0.004)。
临床怎么用
- 对危重烧伤患者使用美罗培南或哌拉西林/他唑巴坦时应关注ARC对药物暴露的影响。
- 基于分离株MIC的目标通常可达成,但基于折点的阈值常不达标,提示需加强治疗药物监测。
局限性
- 样本量较小(24例患者,84份样本)。
- 探索性分析结果需进一步验证。
- 需更多研究明确治疗药物监测和ARC在高风险人群中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burn patients in the intensive care unit (ICU) are at high risk for pharmacokinetic variability, particularly due to augmented renal clearance (ARC), which can compromise β-lactam antibiotic exposure. We aimed to assess the association of ARC with β-lactam target attainment in a burn ICU population. METHODS: We conducted a prospective observational study between 2023 and 2025 in a tertiary burn ICU. Adult patients treated with meropenem or piperacillin/tazobactam were included and had undergone daily drug level and renal function assessments. Plasma drug levels were quantified by high-performance liquid chromatography (HPLC), renal function was assessed using creatinine clearance based on urine creatinine measurement with ARC defined as creatinine clearance > 130 mL/min. Pharmacodynamic target attainment (TA) was defined as 100% ƒT > MIC against both EUCAST breakpoint and isolate-specific MICs. Antibiotic level measurements with concomitant ARC were compared with those without ARC using Fisher's exact test. RESULTS: Of 85 screened patients, 24 received study antibiotics, yielding 84 samples paired with estimated creatinine clearance and minimum inhibitory concentrations (MICs). Target attainment was significantly higher without ARC: 100.0% vs. 71.4% for 100% ƒT > MIC using isolate MICs (OR 0.019 [0.001-0.38], p < 0.001) and 74.6% vs. 38.1% for 100% ƒT > MIC using breakpoint MICs (OR 0.21 [0.07-0.60], p = 0.004). Exploratory analyses indicated preserved renal function and lower organ failure scores were linked to subtherapeutic levels. CONCLUSIONS: ARC was frequent in critically ill burn patients and was associated with significantly reduced β-lactam target attainment. Although isolate-specific MIC targets were usually achieved, breakpoint-based thresholds were frequently subtherapeutic. Further research is needed to clarify the role of therapeutic drug monitoring and ARC in this high-risk population.
引用
- Závorszky L, Szabó BG, Holub L, et al. Impact of augmented renal clearance on piperacillin and meropenem exposure in critically ill adult burn patients: A prospective observational study. Burns. 2026. PMID: 42508095. doi:10.1016/j.burns.2026.108138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。